19
Total investments
8
Early stage
2
Mid stage
4
Late stage
7y
Years active
Portfolio
17 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jun 2025
Backed by Y Combinator. Lumari streamlines supply chain operations with always-on AI digital workers that monitor, coordinate, and take action end-to-end across procurement, sourcing, and more.
Investor
Jun 2025
Ralo is an intelligent, human-friendly way to navigate home loans, especially for first-time buyers. We help you compare offers, understand your options, and avoid the spammy mess most platforms throw at you.
Investor
Jun 2025
We’re building an AI-native accounting firm where accountants collaborate with intelligent agents to deliver superior financial advisory services. Together, they close the books in a fraction of the time traditional firms require.
Investor
Jun 2025
ENABLING NEUROTECHNOLOGY
Paradromics’ Brain-Computer Interface (BCI) platform records brain activity at the highest possible resolution: the individual neuron. Our AI algorithms decode this massive amount of brain-data, enabling the seamless translation of thought into treatments.
THE MISSION
Data-driven BCI-based technologies for brain health
Our technology will help millions with unmet medical needs suffering from paralysis and movement disorders to chronic pain, addiction, depression and other mental health conditions.
ABOUT
Matt Angle Ph.D. (CEO) founded Paradromics to build a high-data-rate BCI platform capable of addressing critical unmet clinical needs. With early funding from the NIH and DARPA, the company developed its core neurotechnology and, by 2019, shifted focus to its first product: the Connexus® BCI.
Connexus is designed to restore communication through text, synthesized speech, and computer control for people with severe motor impairments, including those caused by ALS, stroke, or spinal cord injury. Backed by two FDA Breakthrough Device Designations and a successful first-in-human recording in May 2025, Paradromics is now preparing to launch a clinical trial in late 2025 to evaluate the long-term safety and participant benefits of their first product, the Connexus BCI.
Investor
Jun 2025
Delty is transforming healthcare operations with AI agents.
Learn more at https://delty.ai/
Find us on X at https://x.com/delty_ai
Investor
Apr 2025
Gravitics, Inc. designs and manufactures large space structures, including orbital carriers, cargo logistics spacecraft, and space station modules. Gravitics is redefining space superiority and enabling a new era for commercial development in earth orbit and beyond. Visit gravitics.com to learn more.
Investor
Feb 2025
Inference is the engine that powers AI, and Groq was built from the silicon up to deliver the worlds fastest inference at scale. We pioneered the LPU—the first processor designed specifically for AI inference—and are transforming that innovation into a global cloud platform powering production AI workloads.
With the capital, infrastructure, and team to execute, were uniquely positioned to define the next era of AI infrastructure. The opportunity is massive, and its still wide open. Now lets go build it!
Investor
Jan 2025
Robots have the potential to reshape our existence. Our mission is to leverage robotics to improve universal quality of life. Robots will become one of the most impactful and effective tools humanity has ever created. We believe robots should do the work humans don’t want to do.
We pursue ambitious goals to make this a reality. We’re not satisfied making incremental improvements to the status quo but are driven to change the paradigm altogether. Our robots are versatile, capable of solving numerous tasks with a single embodiment.
Join us on the next phase of our journey as we get our systems out into the world to do the most meaningful work.
Investor
Jan 2025
A modern PPE brand that protects people and the planet. The name AmorSui is derived from Latin, meaning "self love". We empower companies and hospitals to save cost and reduce waste while protecting their employees sustainably.
Investor
Dec 2024
Roam is an Applied AI lab building World Models for highly retentive 3D environments.
Investor
Oct 2024
Range is the all-in-one wealth management dashboard and expert advisory service that empowers high earners to get the most out of their money with investment management, retirement planning, estate planning, tax planning, insurance optimization, and more.
Angel Investor
Mar 2024
Cerebras Systems is the worlds fastest AI inference. We are powering the future of generative AI. We’re a team of pioneering computer architects, deep learning researchers, and engineers building a new class of AI supercomputers from the ground up.
Our flagship system, Cerebras CS-3, is powered by the Wafer Scale Engine 3—the world’s largest and fastest AI processor. CS-3s are effortlessly clustered to create the largest AI supercomputers on Earth, while abstracting away the complexity of traditional distributed computing.
From sub-second inference speeds to breakthrough training performance, Cerebras makes it easier to build and deploy state-of-the-art AI—from proprietary enterprise models to open-source projects downloaded millions of times.
Here’s what makes our platform different:
🔦 Sub-second reasoning – Instant intelligence and real-time responsiveness, even at massive scale
⚡ Blazing-fast inference – Up to 100x performance gains over traditional AI infrastructure
🧠 Agentic AI in action – Models that can plan, act, and adapt autonomously
🌍 Scalable infrastructure – Built to move from prototype to global deployment without friction
Cerebras solutions are available in the Cerebras Cloud or on-prem, serving leading enterprises, research labs, and government agencies worldwide.
👉 Learn more: www.cerebras.ai
Join us: https://cerebras.net/careers/
Angel Investor
Sep 2023
Anduril is not a traditional defense contractor. We are shaping the future of defense, transforming US & allied military capabilities with advanced technology.
We emphasize speed and results and control our products from start to finish, including funding R&D to selling finished products off the shelf. Today, Anduril is in a rapid growth phase, deploying technology in diverse locations and developing path-making products that will change defense forever.
We believe that everyone at Anduril can be a catalyst. Your perspective can change lives, and we want to help you make your mark. Our team includes thinkers and doers working interdependently. We bring the brightest minds and best-in-class talent together with veterans who have lived the problems of our warfighters.
If you like building quickly and seeing your work deployed in the real world, we want you at Anduril. With offices in Orange County, Washington DC, Seattle, Boston, Atlanta, London, and Sydney, our reach is wide.
Check out our careers page at https://www.anduril.com/careers or send us an email at careers@anduril.com.
Show all 17 investments ↓
Experience · 24 entries
All (24)
Investments (19)
Founder (1)
2025
Investor
Jun 2025
Backed by Y Combinator. Lumari streamlines supply chain operations with always-on AI digital workers that monitor, coordinate, and take action end-to-end across procurement, sourcing, and more.
Investor
Jun 2025
Ralo is an intelligent, human-friendly way to navigate home loans, especially for first-time buyers. We help you compare offers, understand your options, and avoid the spammy mess most platforms throw at you.
Investor
Jun 2025
We’re building an AI-native accounting firm where accountants collaborate with intelligent agents to deliver superior financial advisory services. Together, they close the books in a fraction of the time traditional firms require.
Investor
Jun 2025
ENABLING NEUROTECHNOLOGY
Paradromics’ Brain-Computer Interface (BCI) platform records brain activity at the highest possible resolution: the individual neuron. Our AI algorithms decode this massive amount of brain-data, enabling the seamless translation of thought into treatments.
THE MISSION
Data-driven BCI-based technologies for brain health
Our technology will help millions with unmet medical needs suffering from paralysis and movement disorders to chronic pain, addiction, depression and other mental health conditions.
ABOUT
Matt Angle Ph.D. (CEO) founded Paradromics to build a high-data-rate BCI platform capable of addressing critical unmet clinical needs. With early funding from the NIH and DARPA, the company developed its core neurotechnology and, by 2019, shifted focus to its first product: the Connexus® BCI.
Connexus is designed to restore communication through text, synthesized speech, and computer control for people with severe motor impairments, including those caused by ALS, stroke, or spinal cord injury. Backed by two FDA Breakthrough Device Designations and a successful first-in-human recording in May 2025, Paradromics is now preparing to launch a clinical trial in late 2025 to evaluate the long-term safety and participant benefits of their first product, the Connexus BCI.
Show all 24 entries ↓
Investment activity
2019–2025 · 19 investments
Recent (last 2 years)Earlier